These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6475940)

  • 21. The hepoxilin analog PBT-3 inhibits heparin-activated platelet aggregation evoked by ADP.
    Reynaud D; Hinek A; Pace-Asciak CR
    FEBS Lett; 2002 Mar; 515(1-3):58-60. PubMed ID: 11943194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V; Heyns AD
    Thromb Res; 1990 Feb; 57(4):601-9. PubMed ID: 2158153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2.
    Emadi S; Elalamy I; Vargaftig BB; Hatmi M
    Biochim Biophys Acta; 1996 May; 1300(3):226-32. PubMed ID: 8679688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextran 40 reduces heparin-mediated platelet aggregation.
    Sobel M; Adelman B; Greenfield LJ
    J Surg Res; 1986 Apr; 40(4):382-7. PubMed ID: 2422443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
    Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
    Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde.
    Davies JA; Menys VC
    Thromb Res; 1982 Apr; 26(1):31-41. PubMed ID: 7101245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of heparin and alpha 1-acid glycoprotein on thrombin or Activated Thrombofax Reagent-induced platelet aggregation and clot formation.
    Fiedel BA; Costello M; Gewurz H; Hussissian E
    Haemostasis; 1983; 13(2):89-95. PubMed ID: 6873753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
    Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
    Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular events involved in the proaggregating effect of heparin on human platelets.
    Ruggiero M; Fedi S; Bianchini P; Vannucchi S; Chiarugi V
    Biochim Biophys Acta; 1984 Nov; 802(2):372-7. PubMed ID: 6498225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
    Sinha AK; Rao AK; Willis J; Colman RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
    Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
    Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of heparin on platelet aggregation inhibited by PGI2, trifluoperazine and verapamil.
    Weber DR; Nichols WK; Mohammad SF
    Thromb Res; 1986 May; 42(4):477-87. PubMed ID: 3012821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
    Huang TF; Wu YJ; Ouyang C
    Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling.
    Shah BH; Nawaz Z; Pertani SA; Roomi A; Mahmood H; Saeed SA; Gilani AH
    Biochem Pharmacol; 1999 Oct; 58(7):1167-72. PubMed ID: 10484074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro.
    Westwick J; Scully MF; Poll C; Kakkar VV
    Thromb Res; 1986 May; 42(4):435-47. PubMed ID: 3715810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH; Cormack JG; Morales A
    Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of heparin and a semi-synthetic heparin analogue, A73025. II. Some effects on platelet function.
    Michalski R; Lane DA; Kakkar VV
    Br J Haematol; 1977 Oct; 37(2):247-56. PubMed ID: 603758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different platelet specificities of heparin-dependent platelet aggregating factors in heparin-associated immune thrombocytopenia.
    Pfueller SL; David R
    Br J Haematol; 1986 Sep; 64(1):149-59. PubMed ID: 3756098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Action mechanism of the platelet aggregation inducer and inhibitor from Echis carinatus snake venom.
    Teng CM; Ma YH; Ouyang CH
    Biochim Biophys Acta; 1985 Jul; 841(1):8-14. PubMed ID: 3926005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.